The Society of Interventional Oncology (SIO) has announced new officers and a Board of Directors.
Stephen Solomon, chief of Interventional Radiology at Memorial Sloan Kettering Cancer Center in New York, USA, has assumed presidency of SIO, and joins new board officers “to drive strategy and deliver quality resources to medical professionals in the interventional oncology field,” an announcement from the society states.
Solomon has helped pioneer several different technologies to help patients. A majority of his current research is in the field of image-guided tumour ablation and he is exploring ways to augment ablations with immune stimulation and adjuvant therapies. Solomon has been a consultant to the US FDA and a consultant to a number of medical device companies, the announcement informs.
William S Rilling, professor of Radiology and Surgery, at the Medical College of Wisconsin is named president-elect. Rilling is a local and national principal investigator for a number of important interventional oncology (IO) trials and is currently active as a consultant for a number of companies working to improve outcomes in IO.
SIO’s announced list of officers is:
- Stephen Solomon, president
- William Rilling, president-elect
- Riad Salem, treasurer
Further, Alban Denys (Lausanne, Switzerland), Nahum Goldberg (Jerusalem, Israel), Alexis Kelekis (Athens, Greece), Kevin Kim (New Haven, USA) and Costantinos Sofocleous (New York, USA) have been named as the directors-at-large.
The SIO Board of Directors is responsible for governing, supervising and controlling the affairs of the society, in addition to establishing its policies and programmes. Members will work in cooperation with the new officers, other board members, and the society’s staff, the announcement explains.
